Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

37
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
37
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

1.8K
Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
1.8K
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists01:18

Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists

82
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
82
Hormonal Regulation01:33

Hormonal Regulation

32.7K
The renin-aldosterone system is an endocrine system which guides the renal absorption of water and electrolytes, thus managing blood pressure and osmoregulation. Activation of the system begins in the kidneys with a small cluster of cells adjacent to the afferent and efferent blood vessels of the renal corpuscle. As the nephrons are filtering blood, juxtaglomerular cells monitor blood pressure. If they detect a decrease in pressure, they release the hormone renin into the bloodstream.
32.7K
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

376
Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...
376
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

2.2K
Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
2.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Differential burden of diabetic foot ulcers in individuals with type 1 and type 2 diabetes: A narrative review of prevalence, healing, recurrence, and outcomes.

Science progress·2026
Same author

A Non-Interventional, Multicenter, Observational Study to Provide Real World Evidence on the Diagnosis of Chronic Coronary Syndrome In Patients With Diabetes Mellitus In Greece - The CONTACT STUDY.

Hellenic journal of cardiology : HJC = Hellenike kardiologike epitheorese·2026
Same author

Beyond Single-Class Therapy: Real-World Combined Use of GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 2 Diabetes and Atherosclerotic Cardiovascular Disease.

Advances in therapy·2026
Same author

GLP-1-Based Therapies in Type 1 Diabetes: Emerging Evidence on Cardiovascular, Renal, and Safety Outcomes.

Diabetes, obesity & metabolism·2026
Same author

Association of Triglyceride-Glucose Index, Triglyceride/HDL Cholesterol Ratio and Metabolic Score for Insulin Resistance With Asymptomatic Organ Damage in Previously Untreated Patients With Hypertension.

Journal of clinical hypertension (Greenwich, Conn.)·2026
Same author

GLP-1 Receptor Agonist Therapy and Cardiorenal Outcomes in Type 1 Diabetes: A Propensity-Matched Real-World Analysis.

Diabetes, obesity & metabolism·2026

Related Experiment Video

Updated: May 9, 2025

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

43.6K

Endothelial Function Biomarkers in Hypertension.

Panayotis K Vlachakis1, Panagiotis Theofilis1, Efstathios Manios2

  • 11st Department of Cardiology, "Hippokration" General Hospital, National and Kapodistrian University of Athens, Athens, 11527, Greece.

Current Medicinal Chemistry
|May 6, 2025
PubMed
Summary

Hypertension (HTN) is a leading cause of death, driven by endothelial dysfunction. Biomarkers from blood and imaging can detect this dysfunction early, aiding diagnosis and treatment strategies for cardiovascular disease.

Keywords:
Endothelial functionbiomarkerscardiovascular diseasehypertensionnitric oxide.personalized medicine

More Related Videos

Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.2K
Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

17.3K

Related Experiment Videos

Last Updated: May 9, 2025

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000
07:46

Assessing Endothelial Vasodilator Function with the Endo-PAT 2000

Published on: October 15, 2010

43.6K
Assessment of Vascular Function in Patients With Chronic Kidney Disease
08:50

Assessment of Vascular Function in Patients With Chronic Kidney Disease

Published on: June 16, 2014

16.2K
Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test
06:35

Ultrasound Assessment of Endothelial Function: A Technical Guideline of the Flow-mediated Dilation Test

Published on: April 27, 2016

17.3K

Area of Science:

  • Cardiovascular Medicine
  • Biomarker Research
  • Hypertension Pathophysiology

Background:

  • Hypertension (HTN) is a critical cardiovascular risk factor responsible for millions of deaths annually.
  • The pathophysiology of HTN involves complex mechanisms, notably endothelial dysfunction characterized by imbalances in vasoactive substances and inflammation.
  • Early detection of HTN and its complications is vital for effective management and prevention of long-term adverse outcomes.

Purpose of the Study:

  • To explore the role of endothelial function biomarkers in the early detection and understanding of hypertension.
  • To identify key blood- and imaging-based biomarkers indicative of endothelial dysfunction in HTN.
  • To assess the potential of these biomarkers in guiding diagnosis and treatment strategies for hypertensive patients.

Main Methods:

  • Review of existing literature on biomarkers associated with endothelial dysfunction in hypertension.
  • Identification of blood-derived biomarkers such as nitric oxide (NO), asymmetric dimethylarginine (ADMA), matrix metalloproteinases (MMPs), VCAM-1, ICAM-1, and endothelial microparticles.
  • Inclusion of imaging-based biomarkers like flow-mediated dilation (FMD) and coronary flow reserve (CFR).

Main Results:

  • Endothelial dysfunction is a central feature of HTN, contributing to elevated blood pressure and vascular damage.
  • Various blood and imaging biomarkers can effectively indicate inflammation, endothelial dysfunction, and vascular injury in HTN.
  • These biomarkers, alongside blood pressure measurements, enhance early diagnosis and provide insights into disease mechanisms.

Conclusions:

  • Biomarkers of endothelial function hold significant promise for the early detection and improved management of hypertension.
  • Further large-scale, prospective studies are required to fully validate these biomarkers for widespread clinical application.
  • The integration of biomarker analysis with BP monitoring can refine diagnostic accuracy and personalize treatment approaches for cardiovascular disease.